3 Dec 2018 07:00
Surgical Innovations Group plc
("Surgical Innovations" or "the "Company")
Appointment of Nominated Adviser and Broker
Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces the appointment of Nplus1 Singer Advisory LLP ("N+1 Singer") as Nominated Adviser and sole Broker to the Company with immediate effect.
For further information contact:
Surgical Innovations Group Plc | www.sigroupplc.com |
Nigel Rogers, Executive Chairman | Tel: +44 (0)113 230 7597 |
Melanie Ross, COO and CFO | |
Walbrook PR (Financial PR & Investor Relations) | Tel: +44 (0)20 7933 8780 or si@walbrookpr.com |
Paul McManus | Mob: +44 (0)7980 541 893 |
Lianne Cawthorne | Mob: +44 (0)7584 391 303 |
N+1 Singer - Nominated Adviser and Broker | +44 (0)20 7496 3000 |
Richard Lindley | |
Rachel Hayes |
Surgical Innovations (SUN)